Citation: Mj. Arranz et al., Neurotransmitter receptor variants and their influence on antipsychotic treatment (Review), INT J MOL M, 7(1), 2001, pp. 27-30
Authors:
Bolonna, AA
Kerwin, RW
Munro, J
Arranz, MJ
Makoff, AJ
Citation: Aa. Bolonna et al., Polymorphisms in the genes for mGluR types 7 and 8: association studies with schizophrenia, SCHIZOPHR R, 47(1), 2001, pp. 99-103
Authors:
Pariante, CM
Makoff, A
Lovestone, S
Feroli, S
Heyden, A
Miller, AH
Kerwin, RW
Citation: Cm. Pariante et al., Antidepressants enhance glucocorticoid receptor function in vitro by modulating the membrane steroid transporters, BR J PHARM, 134(6), 2001, pp. 1335-1343
Authors:
Bigliani, V
Mulligan, RS
Acton, PD
Ohlsen, RI
Pike, VW
Ell, PJ
Gacinovic, S
Kerwin, RW
Pilowsky, LS
Citation: V. Bigliani et al., Striatal and temporal cortical D2/D3 receptor occupancy by olanzapine and sertindole in vivo: a [I-123]epidepride single photon emission tomography (SPET) study, PSYCHOPHAR, 150(2), 2000, pp. 132-140
Authors:
Aitchison, KJ
Gonzalez, FJ
Quattrochi, LC
Sapone, A
Zhao, JH
Zaher, H
Elizondo, G
Bryant, C
Munro, J
Collier, DA
Makoff, AJ
Kerwin, RW
Citation: Kj. Aitchison et al., Identification of novel polymorphisms in the 5 ' flanking region of CYP1A2, characterization of interethnic variability, and investigation of their functional significance, PHARMACOGEN, 10(8), 2000, pp. 695-704
Authors:
Birkett, JT
Arranz, MJ
Munro, J
Osbourn, S
Kerwin, RW
Collier, DA
Citation: Jt. Birkett et al., Association analysis of the 5-HT5A gene in depression, psychosis and antipsychotic response, NEUROREPORT, 11(9), 2000, pp. 2017-2020
Citation: Mj. Arranz et Rw. Kerwin, Neurotransmitter-related genes and antipsychotic response: pharmacogenetics meets psychiatric treatment, ANN MED, 32(2), 2000, pp. 128-133
Authors:
Bolonna, AA
Arranz, MJ
Munro, J
Osborne, S
Petouni, M
Martinez, M
Kerwin, RW
Citation: Aa. Bolonna et al., No influence of adrenergic receptor polymorphisms on schizophrenia and antipsychotic response, NEUROSCI L, 280(1), 2000, pp. 65-68
Authors:
Bell, R
Munro, J
Russ, C
Powell, JF
Bruinvels, A
Kerwin, RW
Collier, DA
Citation: R. Bell et al., Systematic screening of the 14-3-3 eta (eta) chain gene for polymorphic variants and case-control analysis in schizophrenia, AM J MED G, 96(6), 2000, pp. 736-743
Authors:
Lingford-Hughes, AR
Acton, PD
Gacinovic, S
Boddington, SJA
Costa, DC
Pilowsky, LS
Ell, PJ
Marshall, EJ
Kerwin, RW
Citation: Ar. Lingford-hughes et al., Levels of gamma-aminobutyric acid-benzodiazepine receptors in abstinent, alcohol-dependent women: Preliminary findings from an I-123-iomazenil singlephoton emission tomography study, ALC CLIN EX, 24(9), 2000, pp. 1449-1455
Authors:
Stephenson, CME
Bigliani, V
Jones, HM
Mulligan, RS
Acton, PD
Visvikis, D
Ell, PJ
Kerwin, RW
Pilowsky, LS
Citation: Cme. Stephenson et al., Striatal and extra-striatal D-2/D-3 dopamine receptor occupancy by quetiapine in vivo - [I-123]-epidepride single photon emission tomography (SPET) study, BR J PSYCHI, 177, 2000, pp. 408-415
Authors:
Aitchison, KJ
Munro, J
Wright, P
Smith, S
Makoff, AJ
Sachse, C
Sham, PC
Murray, RM
Collier, DA
Kerwin, RW
Citation: Kj. Aitchison et al., Failure to respond to treatment with typical antipsychotics is not associated with CYP2D6 ultrarapid hydroxylation, BR J CL PH, 48(3), 1999, pp. 388-394
Authors:
Bigliani, V
Mulligan, RS
Acton, PD
Visvikis, D
Ell, PJ
Stephenson, C
Kerwin, RW
Pilowsky, LS
Citation: V. Bigliani et al., In vivo occupancy of striatal and temporal cortical D-2/D-3 dopamine receptors by typical antipsychotic drugs - [I-123]-epidepride single photon emission tomography (SPET) study, BR J PSYCHI, 175, 1999, pp. 231-238
Authors:
Arranz, MJ
Li, T
Munro, J
Liu, X
Murray, R
Collier, DA
Kerwin, RW
Citation: Mj. Arranz et al., Lack of association between a polymorphism in the promoter region of the dopamine-2 receptor gene and clozapine response, PHARMACOGEN, 8(6), 1998, pp. 481-484